サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1753919

哺乳類ポリクローナルIgG抗体市場レポート：タイプ、製品、用途、最終用途、地域別、2025～2033年

Mammalian Polyclonal IgG Antibody Market Report by Type, Product, Application, End Use, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 138 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.72円
哺乳類ポリクローナルIgG抗体市場レポート：タイプ、製品、用途、最終用途、地域別、2025～2033年
出版日: 2025年06月02日
発行: IMARC
ページ情報: 英文 138 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

哺乳類ポリクローナルIgG抗体の世界市場規模は、2024年に11億4,180万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに17億260万米ドルに達し、2025～2033年にかけて4.31%の成長率（CAGR）を示すと予測しています。市場成長の原動力は、研究機関と産業参入企業との共同研究の増加、モノクローナル抗体とポリクローナル抗体研究への注目の高まり、世界のヘルスケアインフラの拡大、自己免疫疾患治療における使用の増加、組み換え抗体の採用の拡大、CRO（医薬品開発業務受託機関）産業の著しい成長などがあります。

哺乳類ポリクローナル免疫グロブリン（IgG）抗体は、マウス、ウサギ、ヤギなど様々な哺乳類に接種して製造される抗原や予防接種を指します。この方法では、IgGを供給するBリンパ球を活性化させるために、哺乳動物の体内に抗原を注射で投与します。これらの抗体は、酵素結合免疫吸着測定法（ELISA）、ウェスタンブロット検査、免疫放射測定法（IRMA）、ラジオイムノアッセイ（RIA）など、複数の免疫測定検査における標識試薬に使用されます。これとは別に、このプロセスは熟練した専門家を必要とせず、大量の予防接種を製造することができます。哺乳類ポリクローナルIgG抗体は、複数の治療の作成、様々な病気の診断、抗体の同定やフローサイトメトリーの実行に役立ちます。その結果、生化学研究において、変性タンパク質の検出、疾患とその治療法の調査など、広範な用途が見出されています。現在、心臓マーカー、代謝マーカー、腎臓マーカーの製品バリエーションが市販されています。

哺乳類ポリクローナルIgG抗体市場動向

慢性疾患の増加

がん、心血管疾患、自己免疫疾患などの慢性疾患の症例数の増加が、哺乳類ポリクローナルIgG抗体市場規模の拡大につながる主要因です。例えば、一般クリニックにおける28の診断記録別、少なくとも1つの慢性疾患を有する25歳以上の有病率は、2004年の34.9%から2011年には41.8%に上昇し、この期間中に6.9ポイントの統計的有意な増加を示しています。これらの疾患はより先進的診断と管理を必要とするため、哺乳類ポリクローナルIgG抗体は免疫測定、指向性治療、免疫系の調節に一般的に使用されています。慢性疾患の持続的な増加により、抗体をベースとした相対的なソリューションやその他のソリューションへのニーズが高まっており、市場のさらなる発展に寄与しています。

治療用抗体に対する需要の高まり

治療用抗体に対する需要の高まりは、哺乳類ポリクローナルIgG抗体市場シェアを拡大する重要な要因です。治療用抗体は、がん、自己免疫疾患、感染症など様々な疾患の治療に使用されるようになってきています。バイオ医薬品企業が抗体ベースの治療法を開発するにつれ、免疫応答の調節や研究用途に不可欠なポリクローナルIgG抗体の需要が拡大しています。さらに、抗体工学の進歩や個別化医療への注目の高まりが、治療用抗体の採用をさらに促進しています。このような需要の高まりは、哺乳類ポリクローナルIgG抗体の研究、開発、生産を促進し、市場の大幅な成長と現代ヘルスケアにおける用途の拡大に寄与しています。

バイオテクノロジーと製薬産業における著しい成長

バイオテクノロジーと製薬産業の成長は、市場の重要な促進要因です。これらの産業の拡大に伴い、革新的な治療・診断ソリューションに関わる研究開発（R&D）活動への投資が増加しています。ポリクローナルIgG抗体は、特にがんや自己免疫疾患のような複雑な疾患に対する創薬、疾病診断、治療開発において重要な役割を果たしています。抗体工学のようなバイオ医薬品技術の絶え間ない進歩や、生物製剤やバイオシミラーの推進もまた、これらの抗体の需要を牽引しており、これらの抗体の生産量の増加や用途の拡大につながっています。加えて、個別化医療や精密治療に対する産業の注目は、高品質の抗体の必要性を高め、市場をさらに活性化させています。

本レポートで扱う主要質問

  • 哺乳類ポリクローナルIgG抗体の世界市場規模は？
  • 2025～2033年にかけての世界の哺乳類ポリクローナルIgG抗体市場の予想成長率は？
  • 哺乳類ポリクローナルIgG抗体の世界市場を牽引する主要因は？
  • 哺乳類ポリクローナルIgG抗体の世界市場におけるCOVID-19の影響は？
  • 哺乳類ポリクローナルIgG抗体の世界市場におけるタイプによる区分は？
  • 哺乳類ポリクローナルIgG抗体の世界市場における製品による区分は？
  • 哺乳類ポリクローナルIgG抗体の世界市場における用途による区分は？
  • 哺乳類ポリクローナルIgG抗体の世界市場における最終用途による市場内訳は？
  • 哺乳類ポリクローナルIgG抗体の世界市場における主要地域は？
  • 哺乳類ポリクローナルIgG抗体の世界市場における主要参入企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界の哺乳類ポリクローナルIgG抗体市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • ヤギ
  • ウサギ
  • ウマ
  • ネズミ
  • その他

第7章 市場内訳：製品別

  • 心臓マーカー
  • 代謝マーカー
  • 腎臓マーカー
  • その他

第8章 市場内訳：用途別

  • ELISA
  • 免疫比濁法
  • 免疫電気泳動
  • 抗体の同定
  • 免疫組織化学
  • 免疫細胞化学
  • ウェスタンブロッティング

第9章 市場内訳：最終用途別

  • 病院
  • 診断センター
  • 学術研究機関

第10章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • AbbIoTec Inc.
    • Abcam plc
    • Bio-Rad Laboratories Inc.
    • Cell Signaling Technology Inc.
    • Creative Diagnostics
    • Elabscience BIoTechnology Inc.
    • Geno Technology Inc.
    • Merck KGaA
    • Proteintech Group Inc.
    • STEMCELL Technologies Inc.
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Mammalian Polyclonal IgG Antibody Market: Major Drivers and Challenges
  • Figure 2: Global: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 4: Global: Mammalian Polyclonal IgG Antibody Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Mammalian Polyclonal IgG Antibody Market: Breakup by Product (in %), 2024
  • Figure 6: Global: Mammalian Polyclonal IgG Antibody Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Mammalian Polyclonal IgG Antibody Market: Breakup by End Use (in %), 2024
  • Figure 8: Global: Mammalian Polyclonal IgG Antibody Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Mammalian Polyclonal IgG Antibody (Goat) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Mammalian Polyclonal IgG Antibody (Goat) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Mammalian Polyclonal IgG Antibody (Rabbit) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Mammalian Polyclonal IgG Antibody (Rabbit) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Mammalian Polyclonal IgG Antibody (Horse) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Mammalian Polyclonal IgG Antibody (Horse) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Mammalian Polyclonal IgG Antibody (Mouse) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Mammalian Polyclonal IgG Antibody (Mouse) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Mammalian Polyclonal IgG Antibody (Other Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Mammalian Polyclonal IgG Antibody (Other Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Mammalian Polyclonal IgG Antibody (Cardiac Markers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Mammalian Polyclonal IgG Antibody (Cardiac Markers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Mammalian Polyclonal IgG Antibody (Metabolic Markers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Mammalian Polyclonal IgG Antibody (Metabolic Markers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Mammalian Polyclonal IgG Antibody (Renal Markers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Mammalian Polyclonal IgG Antibody (Renal Markers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Mammalian Polyclonal IgG Antibody (Other Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Mammalian Polyclonal IgG Antibody (Other Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Mammalian Polyclonal IgG Antibody (ELISA) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Mammalian Polyclonal IgG Antibody (ELISA) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Mammalian Polyclonal IgG Antibody (Immunoturbidimetry) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Mammalian Polyclonal IgG Antibody (Immunoturbidimetry) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Mammalian Polyclonal IgG Antibody (Immunoelectrophoresis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Mammalian Polyclonal IgG Antibody (Immunoelectrophoresis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Mammalian Polyclonal IgG Antibody (Antibody Identification) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Mammalian Polyclonal IgG Antibody (Antibody Identification) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Mammalian Polyclonal IgG Antibody (Immunohistochemistry) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Mammalian Polyclonal IgG Antibody (Immunohistochemistry) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Global: Mammalian Polyclonal IgG Antibody (Immunocytochemistry) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Global: Mammalian Polyclonal IgG Antibody (Immunocytochemistry) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Global: Mammalian Polyclonal IgG Antibody (Western Blotting) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Global: Mammalian Polyclonal IgG Antibody (Western Blotting) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Global: Mammalian Polyclonal IgG Antibody (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Global: Mammalian Polyclonal IgG Antibody (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Global: Mammalian Polyclonal IgG Antibody (Diagnostic Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Global: Mammalian Polyclonal IgG Antibody (Diagnostic Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Global: Mammalian Polyclonal IgG Antibody (Academic and Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Global: Mammalian Polyclonal IgG Antibody (Academic and Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: North America: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: North America: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: United States: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: United States: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Canada: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Canada: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Asia-Pacific: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Asia-Pacific: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: China: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: China: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Japan: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Japan: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: India: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: India: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: South Korea: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: South Korea: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Australia: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Australia: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Indonesia: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Indonesia: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Others: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Others: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Europe: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Europe: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Germany: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Germany: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: France: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: France: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: United Kingdom: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: United Kingdom: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Italy: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Italy: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Spain: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Spain: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Russia: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Russia: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Others: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Others: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Latin America: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 86: Latin America: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Brazil: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 88: Brazil: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 89: Mexico: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 90: Mexico: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 91: Others: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 92: Others: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 93: Middle East and Africa: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 94: Middle East and Africa: Mammalian Polyclonal IgG Antibody Market: Breakup by Country (in %), 2024
  • Figure 95: Middle East and Africa: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 96: Global: Mammalian Polyclonal IgG Antibody Industry: SWOT Analysis
  • Figure 97: Global: Mammalian Polyclonal IgG Antibody Industry: Value Chain Analysis
  • Figure 98: Global: Mammalian Polyclonal IgG Antibody Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Mammalian Polyclonal IgG Antibody Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Mammalian Polyclonal IgG Antibody Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Mammalian Polyclonal IgG Antibody Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 4: Global: Mammalian Polyclonal IgG Antibody Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Mammalian Polyclonal IgG Antibody Market Forecast: Breakup by End Use (in Million USD), 2025-2033
  • Table 6: Global: Mammalian Polyclonal IgG Antibody Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Mammalian Polyclonal IgG Antibody Market: Competitive Structure
  • Table 8: Global: Mammalian Polyclonal IgG Antibody Market: Key Players
目次
Product Code: SR112025A6464

The global mammalian polyclonal IgG antibody market size reached USD 1,141.8 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,702.6 Million by 2033, exhibiting a growth rate (CAGR) of 4.31% during 2025-2033. The market growth is driven by the increasing collaborations between research institutes and industry players, the rising focus on monoclonal and polyclonal antibody research, the expanding global healthcare infrastructure, the growing use in autoimmune disease treatment, the escalating adoption of recombinant antibodies, and significant growth of the contract research organization (CRO) industry.

Mammalian polyclonal immunoglobulins (IgG) antibody refers to antigens or vaccinations that are manufactured through inoculation of various mammals, including mice, rabbits, and goats. During this procedure, an antigen is administered via injectable into the mammal body to activate the B-lymphocytes that supply IgG. These antibodies are used in labeling reagents in multiple immunoassay tests, including enzyme-linked immunosorbent assay (ELISA), western blot tests, immunoradiometric assay (IRMA), and radioimmunoassay (RIA). Apart from this, the process does not require skilled professionals to produce large batches of vaccinations. Mammalian polyclonal IgG antibody helps create multiple therapeutics, diagnose various ailments, and perform antibody identification and flow cytometry. As a result, they find extensive applications in biochemical research to detect denatured proteins and examine diseases and their treatments. At present, they are commercially available in cardiac, metabolic, and renal marker product variants.

Mammalian Polyclonal IgG Antibody Market Trends:

Increasing prevalence of chronic diseases

The increasing number of cases of chronic diseases, such as cancer, cardiovascular disease, and autoimmune diseases, is a major factor leading to the expansion of the mammalian polyclonal IgG antibody market size. For instance, the prevalence of individuals aged 25 and older with at least one chronic disease, based on 28 recorded diagnoses in general practice, rose from 34.9% in 2004 to 41.8% in 2011, reflecting a statistically significant increase of 6.9 percentage points during that period. As these conditions require more sophisticated diagnostics and management, mammalian polyclonal IgG antibodies are commonly used in immunoassays, directed therapy, and modulation of the immune system. Due to the persistent growth in chronic medical conditions, the prevalent need for relative antibody-based and other solutions contributes to the further advancement of the market.

Rising demand for therapeutic antibodies

The rising demand for therapeutic antibodies is a key factor augmenting the mammalian polyclonal IgG antibody market share. Therapeutic antibodies are increasingly used in the treatment of various diseases, including cancer, autoimmune disorders, and infectious diseases, due to their high specificity and ability to target disease-causing agents effectively. As biopharmaceutical companies develop more antibody-based therapies, the demand for polyclonal IgG antibodies, which are essential in immune response modulation and research applications, is growing. Additionally, advancements in antibody engineering and an increased focus on personalized medicine further enhance the adoption of therapeutic antibodies. This rising demand fuels research, development, and production of mammalian polyclonal IgG antibodies, contributing to significant market growth and expanding their applications in modern healthcare.

Significant growth in the biotechnology and pharmaceutical industries

The growth of the biotechnology and pharmaceutical industries is a significant driver of the market. As these industries expand, there has been increasing investments in research and development (R&D) activities involving innovative therapeutic and diagnostic solutions. Polyclonal IgG antibodies play a critical role in drug discovery, disease diagnostics, and therapeutic development, especially for complex diseases like cancer and autoimmune disorders. Continual advancements in biopharmaceutical technologies, such as antibody engineering, and the push for biologics and biosimilars are also driving the demand for these antibodies, leading to increased production and wider applications for these antibodies. Additionally, the industry's focus on personalized medicine and precision therapies increases the need for high-quality antibodies, further providing a boost to the market.

Key Market Segmentation:

Breakup by Type:

  • Goat
  • Rabbit
  • Horse
  • Mouse
  • Others

Breakup by Product:

  • Cardiac Markers
  • Metabolic Markers
  • Renal Markers
  • Others

Breakup by Application:

  • ELISA
  • Immunoturbidimetry
  • Immunoelectrophoresis
  • Antibody Identification
  • Immunohistochemistry
  • Immunocytochemistry
  • Western Blotting

Breakup by End Use:

  • Hospitals
  • Diagnostic Centers
  • Academic and Research Institutes

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global mammalian polyclonal IgG antibody market. Detailed profiles of all major companies have also been provided. Some of the companies covered include:

  • Abbiotec Inc.
  • Abcam plc
  • Bio-Rad Laboratories Inc.
  • Cell Signaling Technology Inc.
  • Creative Diagnostics
  • Elabscience Biotechnology Inc.
  • Geno Technology Inc.
  • Merck KGaA
  • Proteintech Group Inc.
  • STEMCELL Technologies Inc.
  • Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1.How big is the global mammalian polyclonal IgG antibody market?
  • 2.What is the expected growth rate of the global mammalian polyclonal IgG antibody market during 2025-2033?
  • 3.What are the key factors driving the global mammalian polyclonal IgG antibody market?
  • 4.What has been the impact of COVID-19 on the global mammalian polyclonal IgG antibody market?
  • 5.What is the breakup of the global mammalian polyclonal IgG antibody market based on the type?
  • 6.What is the breakup of the global mammalian polyclonal IgG antibody market based on the product?
  • 7.What is the breakup of the global mammalian polyclonal IgG antibody market based on the application?
  • 8.What is the breakup of the global mammalian polyclonal IgG antibody market based on the end use?
  • 9.What are the key regions in the global mammalian polyclonal IgG antibody market?
  • 10.Who are the key players/companies in the global mammalian polyclonal IgG antibody market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Mammalian Polyclonal IgG Antibody Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Goat
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Rabbit
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Horse
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Mouse
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Cardiac Markers
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Metabolic Markers
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Renal Markers
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Application

  • 8.1 ELISA
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Immunoturbidimetry
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Immunoelectrophoresis
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Antibody Identification
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Immunohistochemistry
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Immunocytochemistry
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Western Blotting
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast

9 Market Breakup by End Use

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Diagnostic Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Academic and Research Institutes
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbiotec Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Abcam plc
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bio-Rad Laboratories Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Cell Signaling Technology Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Creative Diagnostics
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Elabscience Biotechnology Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Geno Technology Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Merck KGaA
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Proteintech Group Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 STEMCELL Technologies Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Thermo Fisher Scientific Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis